

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein heterotrimerization (GO:0070208) | 5.08200075 |
| 2 | glomerular filtration (GO:0003094) | 4.74374369 |
| 3 | low-density lipoprotein particle clearance (GO:0034383) | 4.68533162 |
| 4 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 4.49449853 |
| 5 | cell migration involved in heart development (GO:0060973) | 4.30346129 |
| 6 | renal filtration (GO:0097205) | 4.30148630 |
| 7 | keratan sulfate catabolic process (GO:0042340) | 4.11891374 |
| 8 | regulation of sequestering of triglyceride (GO:0010889) | 4.10552539 |
| 9 | ovulation from ovarian follicle (GO:0001542) | 4.09887039 |
| 10 | vascular endothelial growth factor signaling pathway (GO:0038084) | 4.06497199 |
| 11 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.94865342 |
| 12 | basement membrane organization (GO:0071711) | 3.91037839 |
| 13 | fatty acid transmembrane transport (GO:1902001) | 3.88156132 |
| 14 | cardiac myofibril assembly (GO:0055003) | 3.87671974 |
| 15 | endothelium development (GO:0003158) | 3.87424464 |
| 16 | carnitine shuttle (GO:0006853) | 3.81496547 |
| 17 | actin-mediated cell contraction (GO:0070252) | 3.76557545 |
| 18 | plasma membrane repair (GO:0001778) | 3.71406608 |
| 19 | white fat cell differentiation (GO:0050872) | 3.63831454 |
| 20 | collagen fibril organization (GO:0030199) | 3.63312510 |
| 21 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.56722114 |
| 22 | positive regulation of fatty acid oxidation (GO:0046321) | 3.51035759 |
| 23 | heart trabecula formation (GO:0060347) | 3.47384411 |
| 24 | skin morphogenesis (GO:0043589) | 3.43620062 |
| 25 | brown fat cell differentiation (GO:0050873) | 3.42875878 |
| 26 | cellular response to epinephrine stimulus (GO:0071872) | 3.32458799 |
| 27 | triglyceride catabolic process (GO:0019433) | 3.32393653 |
| 28 | sarcomere organization (GO:0045214) | 3.32145926 |
| 29 | metanephric mesenchyme development (GO:0072075) | 3.28534147 |
| 30 | endocrine hormone secretion (GO:0060986) | 3.27380893 |
| 31 | myofibril assembly (GO:0030239) | 3.24943584 |
| 32 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.22389049 |
| 33 | extracellular matrix assembly (GO:0085029) | 3.21656168 |
| 34 | glomerular basement membrane development (GO:0032836) | 3.19465928 |
| 35 | growth hormone receptor signaling pathway (GO:0060396) | 3.17378847 |
| 36 | * collagen metabolic process (GO:0032963) | 3.11794325 |
| 37 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.10441730 |
| 38 | endothelial cell morphogenesis (GO:0001886) | 3.09923726 |
| 39 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.08293676 |
| 40 | * multicellular organismal macromolecule metabolic process (GO:0044259) | 3.08116345 |
| 41 | regulation of fatty acid oxidation (GO:0046320) | 3.06505334 |
| 42 | blood vessel maturation (GO:0001955) | 3.05618028 |
| 43 | regulation of cholesterol storage (GO:0010885) | 3.05603408 |
| 44 | extracellular fibril organization (GO:0043206) | 3.04725633 |
| 45 | trabecula formation (GO:0060343) | 3.04690217 |
| 46 | actin filament-based movement (GO:0030048) | 3.04231402 |
| 47 | negative regulation of fatty acid transport (GO:2000192) | 3.01946873 |
| 48 | lipid particle organization (GO:0034389) | 3.01631713 |
| 49 | * collagen catabolic process (GO:0030574) | 3.01058239 |
| 50 | valine metabolic process (GO:0006573) | 3.00666660 |
| 51 | venous blood vessel morphogenesis (GO:0048845) | 3.00317808 |
| 52 | biotin metabolic process (GO:0006768) | 2.99083072 |
| 53 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.99008991 |
| 54 | acylglycerol catabolic process (GO:0046464) | 2.98410036 |
| 55 | neutral lipid catabolic process (GO:0046461) | 2.98410036 |
| 56 | * multicellular organismal metabolic process (GO:0044236) | 2.97878534 |
| 57 | virion attachment to host cell (GO:0019062) | 2.96115936 |
| 58 | adhesion of symbiont to host cell (GO:0044650) | 2.96115936 |
| 59 | regulation of p38MAPK cascade (GO:1900744) | 2.95979897 |
| 60 | lymph vessel development (GO:0001945) | 2.95260710 |
| 61 | kidney mesenchyme development (GO:0072074) | 2.95135417 |
| 62 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.94464769 |
| 63 | adhesion of symbiont to host (GO:0044406) | 2.93834345 |
| 64 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.92628847 |
| 65 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.90741415 |
| 66 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.89732967 |
| 67 | negative regulation of heart growth (GO:0061117) | 2.89107187 |
| 68 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.89107187 |
| 69 | carnitine transmembrane transport (GO:1902603) | 2.87134864 |
| 70 | response to epinephrine (GO:0071871) | 2.85819607 |
| 71 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.85003977 |
| 72 | axon extension involved in axon guidance (GO:0048846) | 2.85003977 |
| 73 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.84158814 |
| 74 | * multicellular organismal catabolic process (GO:0044243) | 2.83890833 |
| 75 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.76876267 |
| 76 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.76844687 |
| 77 | cellular response to growth hormone stimulus (GO:0071378) | 2.74661159 |
| 78 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.73614856 |
| 79 | actomyosin structure organization (GO:0031032) | 2.72232045 |
| 80 | barbed-end actin filament capping (GO:0051016) | 2.71951196 |
| 81 | positive regulation of vasculogenesis (GO:2001214) | 2.71906485 |
| 82 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.70832492 |
| 83 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.70649671 |
| 84 | heart morphogenesis (GO:0003007) | 2.69671532 |
| 85 | bone trabecula formation (GO:0060346) | 2.69584833 |
| 86 | cardiac muscle cell proliferation (GO:0060038) | 2.68921123 |
| 87 | hemidesmosome assembly (GO:0031581) | 2.68730490 |
| 88 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.67902404 |
| 89 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.67800802 |
| 90 | negative regulation of protein autophosphorylation (GO:0031953) | 2.67629933 |
| 91 | apoptotic cell clearance (GO:0043277) | 2.67622103 |
| 92 | skeletal muscle contraction (GO:0003009) | 2.67125174 |
| 93 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.67106585 |
| 94 | protein localization to cell surface (GO:0034394) | 2.67081918 |
| 95 | * extracellular matrix disassembly (GO:0022617) | 2.66537519 |
| 96 | cGMP-mediated signaling (GO:0019934) | 2.66377064 |
| 97 | myelination in peripheral nervous system (GO:0022011) | 2.66273789 |
| 98 | peripheral nervous system axon ensheathment (GO:0032292) | 2.66273789 |
| 99 | growth hormone secretion (GO:0030252) | 2.65216320 |
| 100 | cell-substrate junction assembly (GO:0007044) | 2.64732070 |
| 101 | fibril organization (GO:0097435) | 2.64169273 |
| 102 | carnitine transport (GO:0015879) | 2.62523855 |
| 103 | amino-acid betaine transport (GO:0015838) | 2.62523855 |
| 104 | actin-myosin filament sliding (GO:0033275) | 2.61840458 |
| 105 | muscle filament sliding (GO:0030049) | 2.61840458 |
| 106 | type B pancreatic cell proliferation (GO:0044342) | 2.61502105 |
| 107 | negative regulation of gluconeogenesis (GO:0045721) | 2.60739938 |
| 108 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.60262491 |
| 109 | positive regulation of macrophage cytokine production (GO:0060907) | 2.59386869 |
| 110 | fibroblast migration (GO:0010761) | 2.59380657 |
| 111 | fatty acid beta-oxidation (GO:0006635) | 2.59118230 |
| 112 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.57847853 |
| 113 | regulation of extracellular matrix disassembly (GO:0010715) | 2.56587262 |
| 114 | endodermal cell differentiation (GO:0035987) | 2.54893625 |
| 115 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.53883462 |
| 116 | phagocytosis, recognition (GO:0006910) | 2.53844380 |
| 117 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.53021959 |
| 118 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 2.52889422 |
| 119 | smooth muscle tissue development (GO:0048745) | 2.52876857 |
| 120 | negative regulation of protein localization to cell surface (GO:2000009) | 2.52841200 |
| 121 | positive regulation of p38MAPK cascade (GO:1900745) | 2.52625224 |
| 122 | * extracellular matrix organization (GO:0030198) | 2.52172346 |
| 123 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.51841204 |
| 124 | negative regulation of cartilage development (GO:0061037) | 2.51306930 |
| 125 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.51294736 |
| 126 | * extracellular structure organization (GO:0043062) | 2.51199587 |
| 127 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.51136806 |
| 128 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.50840854 |
| 129 | positive regulation of glycogen metabolic process (GO:0070875) | 2.49434215 |
| 130 | positive regulation of receptor recycling (GO:0001921) | 2.49059085 |
| 131 | regulation of skeletal muscle contraction (GO:0014819) | 2.47513304 |
| 132 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.47012409 |
| 133 | cellular response to vitamin (GO:0071295) | 2.45188200 |
| 134 | tricarboxylic acid cycle (GO:0006099) | 2.42504671 |
| 135 | stress fiber assembly (GO:0043149) | 2.41616702 |
| 136 | patterning of blood vessels (GO:0001569) | 2.41323136 |
| 137 | ovulation (GO:0030728) | 2.41256013 |
| 138 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.40402974 |
| 139 | regulation of tight junction assembly (GO:2000810) | 2.40247704 |
| 140 | chondrocyte proliferation (GO:0035988) | 2.39985611 |
| 141 | cell proliferation involved in metanephros development (GO:0072203) | 2.38777523 |
| 142 | glucocorticoid biosynthetic process (GO:0006704) | 2.37500443 |
| 143 | extracellular negative regulation of signal transduction (GO:1900116) | 2.37321683 |
| 144 | extracellular regulation of signal transduction (GO:1900115) | 2.37321683 |
| 145 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.32728634 |
| 146 | tooth mineralization (GO:0034505) | 2.32362227 |
| 147 | striated muscle contraction (GO:0006941) | 2.31407166 |
| 148 | sprouting angiogenesis (GO:0002040) | 2.31204376 |
| 149 | positive regulation of protein kinase C signaling (GO:0090037) | 2.30844815 |
| 150 | muscle cell migration (GO:0014812) | 2.30684036 |
| 151 | lymphangiogenesis (GO:0001946) | 2.29352257 |
| 152 | muscle contraction (GO:0006936) | 2.28349362 |
| 153 | cardiac muscle contraction (GO:0060048) | 2.25684512 |
| 154 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.24300369 |
| 155 | complement activation, classical pathway (GO:0006958) | 2.24006056 |
| 156 | transcytosis (GO:0045056) | 2.23719603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.41943519 |
| 2 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 4.14386363 |
| 3 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.32265404 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.94716351 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.85061388 |
| 6 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.79786948 |
| 7 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.65054003 |
| 8 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.64124363 |
| 9 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 2.57126875 |
| 10 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.54286379 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.21372635 |
| 12 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.20510555 |
| 13 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.07562662 |
| 14 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.07562662 |
| 15 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.94887987 |
| 16 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.92635039 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.92583689 |
| 18 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.84554606 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.83626176 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.75482102 |
| 21 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.74067843 |
| 22 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.68010563 |
| 23 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.64996411 |
| 24 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.63588223 |
| 25 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.62299793 |
| 26 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.62130542 |
| 27 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.57821553 |
| 28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.55243031 |
| 29 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.50861193 |
| 30 | * PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.47108174 |
| 31 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.46564132 |
| 32 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45764727 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.45690173 |
| 34 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.44825859 |
| 35 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.43821505 |
| 36 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.42891594 |
| 37 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.41586555 |
| 38 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.40933416 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.36722363 |
| 40 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.33070397 |
| 41 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.30983898 |
| 42 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29821452 |
| 43 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28105374 |
| 44 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.27140016 |
| 45 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.27140016 |
| 46 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.26469143 |
| 47 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.23660591 |
| 48 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.22599196 |
| 49 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21008539 |
| 50 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.19805243 |
| 51 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.19533278 |
| 52 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18213147 |
| 53 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.17935835 |
| 54 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.17794800 |
| 55 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.16924646 |
| 56 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.16594360 |
| 57 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.16175673 |
| 58 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.14867408 |
| 59 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.14352983 |
| 60 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.13922757 |
| 61 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.12136755 |
| 62 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.10606501 |
| 63 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.09648123 |
| 64 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.07751547 |
| 65 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.07100407 |
| 66 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05942476 |
| 67 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05942476 |
| 68 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.05311736 |
| 69 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.05243993 |
| 70 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.04713588 |
| 71 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.04679826 |
| 72 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.04609618 |
| 73 | GATA1_22025678_ChIP-Seq_K562_Human | 1.03054987 |
| 74 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.02833040 |
| 75 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.02341307 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.02128532 |
| 77 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.02063852 |
| 78 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.01770774 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.01454230 |
| 80 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01422653 |
| 81 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.01313840 |
| 82 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.00392113 |
| 83 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00220909 |
| 84 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.99887541 |
| 85 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99883049 |
| 86 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.99852311 |
| 87 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.99049199 |
| 88 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.97483607 |
| 89 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.97424751 |
| 90 | * PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.96957406 |
| 91 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95559976 |
| 92 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95289420 |
| 93 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 0.94882167 |
| 94 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94133842 |
| 95 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.93273786 |
| 96 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.93012579 |
| 97 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.92930015 |
| 98 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.92634139 |
| 99 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.92277669 |
| 100 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.91630589 |
| 101 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.89598626 |
| 102 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.89581197 |
| 103 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 0.89576610 |
| 104 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.88777862 |
| 105 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.88437111 |
| 106 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88284876 |
| 107 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.88229995 |
| 108 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87569098 |
| 109 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.87283945 |
| 110 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87225745 |
| 111 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.86125703 |
| 112 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.85900400 |
| 113 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.85684353 |
| 114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.84934910 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84848943 |
| 116 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84121160 |
| 117 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84083274 |
| 118 | TP53_16413492_ChIP-PET_HCT116_Human | 0.84017256 |
| 119 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.83216875 |
| 120 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.81651962 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 6.28546714 |
| 2 | MP0005275_abnormal_skin_tensile | 4.35871164 |
| 3 | MP0004272_abnormal_basement_membrane | 4.30368017 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.89781893 |
| 5 | MP0005670_abnormal_white_adipose | 3.40335385 |
| 6 | MP0005503_abnormal_tendon_morphology | 3.24762151 |
| 7 | MP0004084_abnormal_cardiac_muscle | 3.00840749 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.99610759 |
| 9 | MP0010368_abnormal_lymphatic_system | 2.97398721 |
| 10 | * MP0000751_myopathy | 2.89973416 |
| 11 | MP0004130_abnormal_muscle_cell | 2.69503164 |
| 12 | MP0005666_abnormal_adipose_tissue | 2.52281192 |
| 13 | MP0003279_aneurysm | 2.34113399 |
| 14 | MP0004215_abnormal_myocardial_fiber | 2.32581463 |
| 15 | MP0004185_abnormal_adipocyte_glucose | 2.17767652 |
| 16 | MP0001958_emphysema | 2.15251936 |
| 17 | MP0005375_adipose_tissue_phenotype | 2.13596418 |
| 18 | MP0004036_abnormal_muscle_relaxation | 2.11833195 |
| 19 | MP0000013_abnormal_adipose_tissue | 2.00259430 |
| 20 | MP0005330_cardiomyopathy | 1.99442039 |
| 21 | MP0003828_pulmonary_edema | 1.99116653 |
| 22 | MP0008775_abnormal_heart_ventricle | 1.96842561 |
| 23 | MP0001879_abnormal_lymphatic_vessel | 1.92949124 |
| 24 | MP0000003_abnormal_adipose_tissue | 1.83741242 |
| 25 | MP0006138_congestive_heart_failure | 1.80906362 |
| 26 | * MP0004087_abnormal_muscle_fiber | 1.72613812 |
| 27 | MP0003566_abnormal_cell_adhesion | 1.68362711 |
| 28 | MP0000749_muscle_degeneration | 1.61872136 |
| 29 | * MP0000750_abnormal_muscle_regeneration | 1.61289317 |
| 30 | MP0001542_abnormal_bone_strength | 1.58410983 |
| 31 | * MP0002108_abnormal_muscle_morphology | 1.57851542 |
| 32 | MP0002972_abnormal_cardiac_muscle | 1.56122717 |
| 33 | MP0005620_abnormal_muscle_contractility | 1.53135507 |
| 34 | MP0003724_increased_susceptibility_to | 1.53016317 |
| 35 | MP0010630_abnormal_cardiac_muscle | 1.50921003 |
| 36 | * MP0001544_abnormal_cardiovascular_syste | 1.50776938 |
| 37 | * MP0005385_cardiovascular_system_phenoty | 1.50776938 |
| 38 | MP0003646_muscle_fatigue | 1.45813644 |
| 39 | MP0001661_extended_life_span | 1.43330715 |
| 40 | MP0003045_fibrosis | 1.40746512 |
| 41 | MP0002060_abnormal_skin_morphology | 1.37219214 |
| 42 | MP0005623_abnormal_meninges_morphology | 1.31107805 |
| 43 | MP0008004_abnormal_stomach_pH | 1.29347000 |
| 44 | MP0002971_abnormal_brown_adipose | 1.26575122 |
| 45 | MP0002933_joint_inflammation | 1.26064506 |
| 46 | MP0000759_abnormal_skeletal_muscle | 1.25474620 |
| 47 | MP0002295_abnormal_pulmonary_circulatio | 1.20493316 |
| 48 | * MP0002106_abnormal_muscle_physiology | 1.18178165 |
| 49 | * MP0005369_muscle_phenotype | 1.17640934 |
| 50 | MP0000343_altered_response_to | 1.16803806 |
| 51 | MP0005167_abnormal_blood-brain_barrier | 1.13271942 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.12430114 |
| 53 | MP0000767_abnormal_smooth_muscle | 1.11783606 |
| 54 | MP0005508_abnormal_skeleton_morphology | 1.11028847 |
| 55 | MP0009115_abnormal_fat_cell | 1.10162351 |
| 56 | MP0004484_altered_response_of | 1.09297666 |
| 57 | MP0000733_abnormal_muscle_development | 1.05138337 |
| 58 | MP0006054_spinal_hemorrhage | 1.02601373 |
| 59 | MP0009780_abnormal_chondrocyte_physiolo | 1.01444422 |
| 60 | MP0004858_abnormal_nervous_system | 0.98059643 |
| 61 | MP0003950_abnormal_plasma_membrane | 0.97750600 |
| 62 | MP0002128_abnormal_blood_circulation | 0.97251961 |
| 63 | MP0005171_absent_coat_pigmentation | 0.96921390 |
| 64 | MP0003191_abnormal_cellular_cholesterol | 0.96160154 |
| 65 | MP0002166_altered_tumor_susceptibility | 0.94376459 |
| 66 | MP0002168_other_aberrant_phenotype | 0.93693142 |
| 67 | MP0002127_abnormal_cardiovascular_syste | 0.93567056 |
| 68 | MP0000747_muscle_weakness | 0.93194913 |
| 69 | MP0002269_muscular_atrophy | 0.93170802 |
| 70 | MP0002896_abnormal_bone_mineralization | 0.92940448 |
| 71 | MP0005334_abnormal_fat_pad | 0.89804425 |
| 72 | MP0005595_abnormal_vascular_smooth | 0.89470247 |
| 73 | MP0004510_myositis | 0.88055880 |
| 74 | MP0000266_abnormal_heart_morphology | 0.87250221 |
| 75 | MP0003941_abnormal_skin_development | 0.86494136 |
| 76 | MP0010329_abnormal_lipoprotein_level | 0.85962597 |
| 77 | MP0004085_abnormal_heartbeat | 0.85320022 |
| 78 | MP0005409_darkened_coat_color | 0.82704208 |
| 79 | * MP0001614_abnormal_blood_vessel | 0.81184753 |
| 80 | MP0002925_abnormal_cardiovascular_devel | 0.79511463 |
| 81 | MP0003300_gastrointestinal_ulcer | 0.79332418 |
| 82 | MP0005388_respiratory_system_phenotype | 0.78551638 |
| 83 | MP0002133_abnormal_respiratory_system | 0.78551638 |
| 84 | MP0005187_abnormal_penis_morphology | 0.78318738 |
| 85 | MP0005257_abnormal_intraocular_pressure | 0.77465907 |
| 86 | MP0003091_abnormal_cell_migration | 0.76498471 |
| 87 | MP0003137_abnormal_impulse_conducting | 0.76052239 |
| 88 | MP0000462_abnormal_digestive_system | 0.75422698 |
| 89 | MP0002115_abnormal_skeleton_extremities | 0.72624383 |
| 90 | MP0002970_abnormal_white_adipose | 0.71785015 |
| 91 | MP0003385_abnormal_body_wall | 0.71693923 |
| 92 | MP0009250_abnormal_appendicular_skeleto | 0.70056105 |
| 93 | MP0002006_tumorigenesis | 0.69860233 |
| 94 | MP0000249_abnormal_blood_vessel | 0.69749140 |
| 95 | MP0010352_gastrointestinal_tract_polyps | 0.67846168 |
| 96 | MP0004134_abnormal_chest_morphology | 0.67495458 |
| 97 | MP0001243_abnormal_dermal_layer | 0.67021994 |
| 98 | MP0005165_increased_susceptibility_to | 0.65017789 |
| 99 | MP0001756_abnormal_urination | 0.64920494 |
| 100 | MP0001299_abnormal_eye_distance/ | 0.64061488 |
| 101 | MP0000230_abnormal_systemic_arterial | 0.63432745 |
| 102 | MP0002998_abnormal_bone_remodeling | 0.63062326 |
| 103 | MP0000534_abnormal_ureter_morphology | 0.62944660 |
| 104 | MP0002118_abnormal_lipid_homeostasis | 0.62263709 |
| 105 | MP0005164_abnormal_response_to | 0.62129766 |
| 106 | MP0002332_abnormal_exercise_endurance | 0.61210370 |
| 107 | MP0003567_abnormal_fetal_cardiomyocyte | 0.59822161 |
| 108 | MP0005023_abnormal_wound_healing | 0.59758008 |
| 109 | MP0000163_abnormal_cartilage_morphology | 0.59751348 |
| 110 | MP0003959_abnormal_lean_body | 0.59207342 |
| 111 | MP0009384_cardiac_valve_regurgitation | 0.58019185 |
| 112 | MP0005076_abnormal_cell_differentiation | 0.58005905 |
| 113 | MP0002254_reproductive_system_inflammat | 0.57153964 |
| 114 | MP0005390_skeleton_phenotype | 0.56582106 |
| 115 | MP0004233_abnormal_muscle_weight | 0.56174292 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Broad metatarsal (HP:0001783) | 5.34559423 |
| 2 | Protrusio acetabuli (HP:0003179) | 5.22571570 |
| 3 | Increased connective tissue (HP:0009025) | 5.21066536 |
| 4 | Ankle contracture (HP:0006466) | 4.68064486 |
| 5 | Muscle fiber splitting (HP:0003555) | 4.59044013 |
| 6 | Cerebral aneurysm (HP:0004944) | 4.52496837 |
| 7 | Premature rupture of membranes (HP:0001788) | 4.47085418 |
| 8 | Type 1 muscle fiber predominance (HP:0003803) | 4.46637731 |
| 9 | Distal arthrogryposis (HP:0005684) | 4.39265865 |
| 10 | Aortic dissection (HP:0002647) | 4.08324315 |
| 11 | Shallow orbits (HP:0000586) | 3.76349387 |
| 12 | Increased variability in muscle fiber diameter (HP:0003557) | 3.73400022 |
| 13 | Nemaline bodies (HP:0003798) | 3.72786725 |
| 14 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.61971689 |
| 15 | Sudden death (HP:0001699) | 3.61904719 |
| 16 | Muscle fiber inclusion bodies (HP:0100299) | 3.58624797 |
| 17 | Follicular hyperkeratosis (HP:0007502) | 3.57298964 |
| 18 | Hyporeflexia of lower limbs (HP:0002600) | 3.56834429 |
| 19 | Ulnar deviation of the wrist (HP:0003049) | 3.49149782 |
| 20 | Spinal rigidity (HP:0003306) | 3.48611467 |
| 21 | Lipoatrophy (HP:0100578) | 3.36477944 |
| 22 | Aortic aneurysm (HP:0004942) | 3.26639575 |
| 23 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.24504230 |
| 24 | Vascular tortuosity (HP:0004948) | 3.21586661 |
| 25 | Ventricular tachycardia (HP:0004756) | 3.21318445 |
| 26 | Difficulty running (HP:0009046) | 3.19936616 |
| 27 | Soft skin (HP:0000977) | 3.11329070 |
| 28 | Right ventricular cardiomyopathy (HP:0011663) | 3.11036970 |
| 29 | Mitral valve prolapse (HP:0001634) | 3.09342444 |
| 30 | Bladder diverticulum (HP:0000015) | 3.03039187 |
| 31 | Atrophic scars (HP:0001075) | 3.00765928 |
| 32 | Calcaneovalgus deformity (HP:0001848) | 3.00451933 |
| 33 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.94343057 |
| 34 | Slender build (HP:0001533) | 2.93981377 |
| 35 | Fragile skin (HP:0001030) | 2.92555629 |
| 36 | Breech presentation (HP:0001623) | 2.83289515 |
| 37 | Abnormality of the 4th metacarpal (HP:0010012) | 2.76315057 |
| 38 | Aneurysm (HP:0002617) | 2.75719106 |
| 39 | Neonatal short-limb short stature (HP:0008921) | 2.74482888 |
| 40 | Arterial tortuosity (HP:0005116) | 2.74411857 |
| 41 | Deformed tarsal bones (HP:0008119) | 2.68375160 |
| 42 | Short 4th metacarpal (HP:0010044) | 2.68197803 |
| 43 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.68197803 |
| 44 | Striae distensae (HP:0001065) | 2.66490337 |
| 45 | Atrial fibrillation (HP:0005110) | 2.64557178 |
| 46 | Abnormality of dentin (HP:0010299) | 2.62428654 |
| 47 | Cervical subluxation (HP:0003308) | 2.61361019 |
| 48 | Acanthosis nigricans (HP:0000956) | 2.58178974 |
| 49 | Dilatation of the ascending aorta (HP:0005111) | 2.57461341 |
| 50 | Pulmonary artery stenosis (HP:0004415) | 2.57072595 |
| 51 | Rectal prolapse (HP:0002035) | 2.55220644 |
| 52 | Calf muscle hypertrophy (HP:0008981) | 2.49173546 |
| 53 | Vertebral compression fractures (HP:0002953) | 2.48426863 |
| 54 | Hypoplasia of the iris (HP:0007676) | 2.48287753 |
| 55 | Myotonia (HP:0002486) | 2.46562422 |
| 56 | Supraventricular arrhythmia (HP:0005115) | 2.44933247 |
| 57 | Peritonitis (HP:0002586) | 2.44392320 |
| 58 | Exercise-induced myalgia (HP:0003738) | 2.42433706 |
| 59 | Wrist flexion contracture (HP:0001239) | 2.42322767 |
| 60 | Neck muscle weakness (HP:0000467) | 2.41665279 |
| 61 | Abnormal delivery (HP:0001787) | 2.41533503 |
| 62 | Abnormality of the calf musculature (HP:0001430) | 2.41109409 |
| 63 | Primary atrial arrhythmia (HP:0001692) | 2.40619547 |
| 64 | Limited hip movement (HP:0008800) | 2.39545971 |
| 65 | Lymphangioma (HP:0100764) | 2.34782928 |
| 66 | Oligomenorrhea (HP:0000876) | 2.33035843 |
| 67 | Biconcave vertebral bodies (HP:0004586) | 2.32727493 |
| 68 | Hypoplastic ischia (HP:0003175) | 2.31942542 |
| 69 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.30173368 |
| 70 | Subaortic stenosis (HP:0001682) | 2.30173368 |
| 71 | Myoglobinuria (HP:0002913) | 2.29284092 |
| 72 | Overgrowth (HP:0001548) | 2.29194288 |
| 73 | Hyperextensible skin (HP:0000974) | 2.27526294 |
| 74 | Venous abnormality (HP:0002624) | 2.25539193 |
| 75 | Supraventricular tachycardia (HP:0004755) | 2.25134100 |
| 76 | Bone cyst (HP:0012062) | 2.22652152 |
| 77 | Venous insufficiency (HP:0005293) | 2.21296734 |
| 78 | Nonimmune hydrops fetalis (HP:0001790) | 2.20890425 |
| 79 | Aortic regurgitation (HP:0001659) | 2.20656299 |
| 80 | Absent phalangeal crease (HP:0006109) | 2.17617361 |
| 81 | Bowel diverticulosis (HP:0005222) | 2.16371585 |
| 82 | Abnormality of the ischium (HP:0003174) | 2.14748048 |
| 83 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.13694829 |
| 84 | Distal lower limb muscle weakness (HP:0009053) | 2.13297560 |
| 85 | Blue sclerae (HP:0000592) | 2.08414663 |
| 86 | Asymmetric septal hypertrophy (HP:0001670) | 2.08286806 |
| 87 | Prolonged QT interval (HP:0001657) | 2.08003644 |
| 88 | Round ear (HP:0100830) | 2.07840493 |
| 89 | Exercise-induced muscle cramps (HP:0003710) | 2.07033238 |
| 90 | Dilated cardiomyopathy (HP:0001644) | 2.05979367 |
| 91 | Hematochezia (HP:0002573) | 2.05943118 |
| 92 | Abnormality of complement system (HP:0005339) | 2.04378752 |
| 93 | Joint laxity (HP:0001388) | 2.04082088 |
| 94 | Bronchomalacia (HP:0002780) | 2.03165215 |
| 95 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.00274929 |
| 96 | Complement deficiency (HP:0004431) | 1.97973974 |
| 97 | Difficulty climbing stairs (HP:0003551) | 1.97058658 |
| 98 | Metatarsus adductus (HP:0001840) | 1.96631286 |
| 99 | Hemorrhage of the eye (HP:0011885) | 1.96623363 |
| 100 | Ectopia lentis (HP:0001083) | 1.94172316 |
| 101 | Elbow flexion contracture (HP:0002987) | 1.94127406 |
| 102 | Hypoventilation (HP:0002791) | 1.93880975 |
| 103 | Mitral regurgitation (HP:0001653) | 1.93519257 |
| 104 | Scapular winging (HP:0003691) | 1.93471070 |
| 105 | Trismus (HP:0000211) | 1.91261388 |
| 106 | Abnormality of the calcaneus (HP:0008364) | 1.90686178 |
| 107 | Joint stiffness (HP:0001387) | 1.89743596 |
| 108 | Toxemia of pregnancy (HP:0100603) | 1.89254964 |
| 109 | Wide anterior fontanel (HP:0000260) | 1.88323500 |
| 110 | Generalized amyotrophy (HP:0003700) | 1.88079890 |
| 111 | EMG: myopathic abnormalities (HP:0003458) | 1.88011394 |
| 112 | Enlarged penis (HP:0000040) | 1.87712645 |
| 113 | Bundle branch block (HP:0011710) | 1.87459467 |
| 114 | Thin bony cortex (HP:0002753) | 1.87444464 |
| 115 | Hip contracture (HP:0003273) | 1.85359035 |
| 116 | Neoplasm of the heart (HP:0100544) | 1.84812265 |
| 117 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.84477524 |
| 118 | Facial diplegia (HP:0001349) | 1.84071552 |
| 119 | Genu recurvatum (HP:0002816) | 1.83928935 |
| 120 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.83482968 |
| 121 | Abnormality of the parietal bone (HP:0002696) | 1.82423063 |
| 122 | Mitral stenosis (HP:0001718) | 1.81962101 |
| 123 | Polycythemia (HP:0001901) | 1.81189005 |
| 124 | Systemic lupus erythematosus (HP:0002725) | 1.80707737 |
| 125 | Spondylolisthesis (HP:0003302) | 1.80627991 |
| 126 | Infantile muscular hypotonia (HP:0008947) | 1.77416154 |
| 127 | Protruding ear (HP:0000411) | 1.77406768 |
| 128 | Distal lower limb amyotrophy (HP:0008944) | 1.75438099 |
| 129 | Mild short stature (HP:0003502) | 1.75108300 |
| 130 | Knee flexion contracture (HP:0006380) | 1.75101675 |
| 131 | Aortic valve stenosis (HP:0001650) | 1.74035782 |
| 132 | Syncope (HP:0001279) | 1.73116622 |
| 133 | Wormian bones (HP:0002645) | 1.70623907 |
| 134 | Disproportionate tall stature (HP:0001519) | 1.70275176 |
| 135 | Limb-girdle muscle weakness (HP:0003325) | 1.69389171 |
| 136 | Osteolytic defects of the hand bones (HP:0009699) | 1.69008524 |
| 137 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.69008524 |
| 138 | Broad ribs (HP:0000885) | 1.68720307 |
| 139 | Midline defect of the nose (HP:0004122) | 1.66660725 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 4.56283576 |
| 2 | TRIB3 | 4.10828558 |
| 3 | TTN | 3.31341741 |
| 4 | CAMK1D | 3.11760249 |
| 5 | TGFBR2 | 3.05907725 |
| 6 | RIPK1 | 3.05693625 |
| 7 | SIK1 | 2.98835822 |
| 8 | CAMK1G | 2.63335784 |
| 9 | MYLK | 2.32407354 |
| 10 | PDGFRA | 2.32317137 |
| 11 | LMTK2 | 2.26514036 |
| 12 | PIK3CG | 2.23996246 |
| 13 | AKT3 | 2.23665826 |
| 14 | DMPK | 2.19348252 |
| 15 | LATS1 | 2.18936339 |
| 16 | PKN2 | 2.13129622 |
| 17 | ERN1 | 1.92847322 |
| 18 | KDR | 1.89540780 |
| 19 | EPHB2 | 1.81599981 |
| 20 | FGFR2 | 1.80613992 |
| 21 | DDR2 | 1.74671349 |
| 22 | PDK4 | 1.74482313 |
| 23 | PDK3 | 1.74482313 |
| 24 | KIT | 1.61819279 |
| 25 | PIK3CA | 1.60346479 |
| 26 | EPHB1 | 1.59424712 |
| 27 | INSRR | 1.56420429 |
| 28 | BCKDK | 1.50503787 |
| 29 | PHKG1 | 1.43021870 |
| 30 | PHKG2 | 1.43021870 |
| 31 | PDK2 | 1.33876843 |
| 32 | PTK2B | 1.33788857 |
| 33 | FER | 1.28914950 |
| 34 | OBSCN | 1.25364726 |
| 35 | PTK6 | 1.20649681 |
| 36 | TGFBR1 | 1.19745419 |
| 37 | FGFR3 | 1.19357767 |
| 38 | NTRK1 | 1.18467744 |
| 39 | PRKD1 | 1.11958981 |
| 40 | FGFR4 | 1.11273977 |
| 41 | PRKAA2 | 1.08589043 |
| 42 | PDGFRB | 1.05285232 |
| 43 | MAP3K3 | 1.01316755 |
| 44 | PRKD3 | 1.00662317 |
| 45 | TESK1 | 0.98005459 |
| 46 | JAK1 | 0.92628725 |
| 47 | PRKCH | 0.92359676 |
| 48 | EPHA3 | 0.92235883 |
| 49 | ABL2 | 0.91367687 |
| 50 | LATS2 | 0.87193615 |
| 51 | PAK2 | 0.85246512 |
| 52 | MAPK4 | 0.85215972 |
| 53 | NLK | 0.83485385 |
| 54 | MUSK | 0.82898124 |
| 55 | MET | 0.82815088 |
| 56 | MAP3K7 | 0.81826198 |
| 57 | FGFR1 | 0.81310798 |
| 58 | MST1R | 0.80177929 |
| 59 | MTOR | 0.80133324 |
| 60 | RET | 0.80025665 |
| 61 | ILK | 0.77703462 |
| 62 | ICK | 0.77661760 |
| 63 | BMX | 0.76369759 |
| 64 | PTK2 | 0.74238987 |
| 65 | MAP2K3 | 0.72957352 |
| 66 | ADRBK1 | 0.71284098 |
| 67 | ROCK1 | 0.68346576 |
| 68 | MAPK12 | 0.66432571 |
| 69 | TRPM7 | 0.66408764 |
| 70 | NEK9 | 0.65243162 |
| 71 | FRK | 0.65077157 |
| 72 | STK3 | 0.64567048 |
| 73 | GSK3A | 0.64487435 |
| 74 | PRKAA1 | 0.63838423 |
| 75 | MAP3K13 | 0.63750747 |
| 76 | GRK5 | 0.63073769 |
| 77 | JAK2 | 0.58167945 |
| 78 | PAK3 | 0.58081492 |
| 79 | CAMK4 | 0.57773286 |
| 80 | MAP3K10 | 0.57256759 |
| 81 | MOS | 0.55912398 |
| 82 | HIPK2 | 0.53955651 |
| 83 | MARK2 | 0.53797914 |
| 84 | STK38L | 0.53773205 |
| 85 | CSK | 0.50148317 |
| 86 | PRKG2 | 0.49776208 |
| 87 | ZAP70 | 0.48877512 |
| 88 | LRRK2 | 0.48500343 |
| 89 | PAK4 | 0.48147700 |
| 90 | LIMK1 | 0.47619497 |
| 91 | CDC42BPA | 0.47478362 |
| 92 | CAMK2G | 0.47335596 |
| 93 | MAP2K1 | 0.46871819 |
| 94 | PRKD2 | 0.46288534 |
| 95 | TYK2 | 0.45997137 |
| 96 | IGF1R | 0.45541405 |
| 97 | PDPK1 | 0.44924801 |
| 98 | WNK4 | 0.44306005 |
| 99 | KSR2 | 0.43850598 |
| 100 | WNK1 | 0.43170762 |
| 101 | CDK6 | 0.41551895 |
| 102 | FLT3 | 0.40573286 |
| 103 | RPS6KC1 | 0.39532880 |
| 104 | RPS6KL1 | 0.39532880 |
| 105 | PRPF4B | 0.38188163 |
| 106 | MAPKAPK3 | 0.37491857 |
| 107 | PRKG1 | 0.36829591 |
| 108 | INSR | 0.36220219 |
| 109 | CDK9 | 0.36190570 |
| 110 | SRC | 0.35847667 |
| 111 | MAP3K1 | 0.35064849 |
| 112 | MAP3K6 | 0.33153260 |
| 113 | STK24 | 0.33051956 |
| 114 | CAMK1 | 0.32152625 |
| 115 | CAMK2D | 0.31797223 |
| 116 | MARK1 | 0.31435491 |
| 117 | GRK1 | 0.30774900 |
| 118 | PRKCE | 0.29942485 |
| 119 | PRKACG | 0.29786630 |
| 120 | ROCK2 | 0.29425874 |
| 121 | MAPK3 | 0.29274077 |
| 122 | SGK3 | 0.27966658 |
| 123 | JAK3 | 0.27380186 |
| 124 | STK38 | 0.25800689 |
| 125 | PDK1 | 0.25030228 |
| 126 | DAPK3 | 0.21584030 |
| 127 | MAPK7 | 0.21542310 |
| 128 | EEF2K | 0.21428047 |
| 129 | RPS6KA2 | 0.20910203 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.38667166 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.01742361 |
| 3 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.87203073 |
| 4 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.61401000 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.51465726 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.42612603 |
| 7 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.37496053 |
| 8 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.27590700 |
| 9 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.20975968 |
| 10 | Focal adhesion_Homo sapiens_hsa04510 | 2.20439734 |
| 11 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.16473464 |
| 12 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.10799227 |
| 13 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 2.00292607 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.92077756 |
| 15 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.86120040 |
| 16 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.71904145 |
| 17 | Amoebiasis_Homo sapiens_hsa05146 | 1.67246999 |
| 18 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.60213629 |
| 19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.58195019 |
| 20 | Insulin resistance_Homo sapiens_hsa04931 | 1.57037172 |
| 21 | Viral myocarditis_Homo sapiens_hsa05416 | 1.55040089 |
| 22 | Adherens junction_Homo sapiens_hsa04520 | 1.43207703 |
| 23 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.40073061 |
| 24 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.39251224 |
| 25 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.38167998 |
| 26 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.25854169 |
| 27 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.20444872 |
| 28 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.18210651 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.17415595 |
| 30 | Renin secretion_Homo sapiens_hsa04924 | 1.17261605 |
| 31 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14099484 |
| 32 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.12374908 |
| 33 | Carbon metabolism_Homo sapiens_hsa01200 | 1.06632107 |
| 34 | Lysine degradation_Homo sapiens_hsa00310 | 1.04779278 |
| 35 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.04726116 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.02138269 |
| 37 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.02051805 |
| 38 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.98293323 |
| 39 | Malaria_Homo sapiens_hsa05144 | 0.97142629 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.96726882 |
| 41 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.93698939 |
| 42 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.93004982 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 0.92694244 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.91263587 |
| 45 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.90415334 |
| 46 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.88958481 |
| 47 | Circadian rhythm_Homo sapiens_hsa04710 | 0.87221619 |
| 48 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.85631571 |
| 49 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.85018375 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 0.83042949 |
| 51 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.82701942 |
| 52 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.82646153 |
| 53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.81182057 |
| 54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.81042089 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.78951526 |
| 56 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.78775288 |
| 57 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.78476382 |
| 58 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.78464385 |
| 59 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.78085871 |
| 60 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.77768536 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.76177474 |
| 62 | Histidine metabolism_Homo sapiens_hsa00340 | 0.75234633 |
| 63 | Pathways in cancer_Homo sapiens_hsa05200 | 0.73658821 |
| 64 | Pertussis_Homo sapiens_hsa05133 | 0.72730299 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.71621878 |
| 66 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.69566672 |
| 67 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.67622233 |
| 68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.67468899 |
| 69 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.67270763 |
| 70 | Glioma_Homo sapiens_hsa05214 | 0.66983279 |
| 71 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.66857576 |
| 72 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66580239 |
| 73 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.66472454 |
| 74 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66101051 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64412214 |
| 76 | Tight junction_Homo sapiens_hsa04530 | 0.63862380 |
| 77 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.63818304 |
| 78 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.62846976 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62732533 |
| 80 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.62302130 |
| 81 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.61927432 |
| 82 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.60273074 |
| 83 | Bile secretion_Homo sapiens_hsa04976 | 0.60123266 |
| 84 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.60062498 |
| 85 | Melanoma_Homo sapiens_hsa05218 | 0.58330012 |
| 86 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58040107 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58009989 |
| 88 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.56192188 |
| 89 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.55986968 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.54688650 |
| 91 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.51245053 |
| 92 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.51107531 |
| 93 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50894700 |
| 94 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49785765 |
| 95 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.49495407 |
| 96 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46362046 |
| 97 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44782689 |
| 98 | Prostate cancer_Homo sapiens_hsa05215 | 0.44736295 |
| 99 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.44644082 |
| 100 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.44431368 |
| 101 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44342713 |
| 102 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.44324888 |
| 103 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43692937 |
| 104 | Axon guidance_Homo sapiens_hsa04360 | 0.43491434 |
| 105 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.41362962 |
| 106 | Salivary secretion_Homo sapiens_hsa04970 | 0.39724125 |
| 107 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.38876042 |
| 108 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.38618052 |
| 109 | Prion diseases_Homo sapiens_hsa05020 | 0.38218791 |
| 110 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.37985811 |
| 111 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.37417428 |
| 112 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.36845545 |
| 113 | Melanogenesis_Homo sapiens_hsa04916 | 0.36710117 |
| 114 | Endometrial cancer_Homo sapiens_hsa05213 | 0.36509891 |
| 115 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.36423706 |
| 116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.35734340 |
| 117 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.35731692 |
| 118 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.35665280 |
| 119 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.35645111 |
| 120 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.35478841 |
| 121 | ABC transporters_Homo sapiens_hsa02010 | 0.35251873 |
| 122 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.35018697 |
| 123 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34627871 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.34120377 |
| 125 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.33466387 |

